Nivolumab (Opdivo)

Science-Based Antibody Drug, Which Opened a New Category of Cancer Treatments

Bibliographic Data

ID20060010
AuthorsYasushi HARA (0000-0002-0528-3252, Hitotsubashi University, corresponding author), Sadao Nagaoka (0000-0002-9291-5763, Tokyo Keizai University)
Year2019
Pages255-283
Publication date2019-01-01
Open AccessYes
TypeCHAPTER
VenueDrug Discovery in Japan (SOURCE_BOOK)
PublisherSpringer Singapore (PUBLISHER • SG)
DOI10.1007/978-981-13-8906-1_14
OpenAlexW2982213225
ISBN9789811389061
LanguageEN
References cited29

Tools

Open DOILibgen